+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305520
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Alopecia Treatment Market grew from USD 4.85 billion in 2023 to USD 5.27 billion in 2024. It is expected to continue growing at a CAGR of 8.89%, reaching USD 8.81 billion by 2030.
Alopecia treatment encompasses a range of medical and cosmetic strategies used to address hair loss, which can be due to genetic factors, autoimmune disorders, medications, or other health conditions. Treatments vary from topical applications and oral medications to advanced therapies such as hair transplant surgeries and light therapy. The primary drivers include the rising prevalence of alopecia conditions due to factors such as stress, hormonal imbalances, and unhealthy lifestyles. Furthermore, technological advancements in hair transplant procedures and public awareness around hair loss treatments contribute to its use. Increased disposable income globally also allows more individuals access to these treatments. However, the high costs of surgical treatments and potential side effects associated with long-term pharmacological therapies act as significant restraining factors. The lack of reimbursement policies for hair loss procedures further hinders its use. The stringent regulatory approval process for new treatments can impede the launch of innovative solutions. Moreover, there is a substantial challenge in meeting diverse consumer expectations and maintaining ethical standards in marketing cosmetic treatments. Significant opportunities include the potential for new treatment formulations and less invasive surgical techniques, which may offer safer options with reduced recovery times.

Regional Insights

The market in the Americas, especially in the United States and Canada, is showing robust growth. This can be attributed to a high prevalence of alopecia driven by lifestyle factors and genetic predispositions. Additionally, strong healthcare infrastructure and the presence of key biotechnology and pharmaceutical companies in the region enhance access to treatment options. There is also a significant focus on aesthetic appearance in these cultures, which propels the need for effective treatment solutions. Europe, with its advanced healthcare systems and high awareness regarding alopecia, showcases the rapid adoption of alopecia treatments. In the Middle East, increasing disposable income and a growing focus on personal well-being are contributing to the adoption of alopecia treatments. Asia-Pacific is witnessing rapid adoption of alopecia treatment, largely driven by increasing economic prosperity, greater healthcare expenditures, and a rising middle class. Moreover, cultural factors and increasing urbanization in countries including China, India, and Japan also contribute to a greater prevalence of stress-related alopecia, further driving the need for treatment solutions.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Alopecia Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing incidence of androgenetic alopecia and alopecia areata diseases
  • Growing awareness about hair loss and transplantation
  • Rise in income levels and increased healthcare spending

Market Restraints

  • Lack of reimbursement policies for alopecia treatments

Market Opportunities

  • Emergence of new alopecia areata treatments and therapeutics
  • Rising investments and expansion of hair transplant clinics

Market Challenges

  • Issues associated with efficacy and side-effects related to some hair loss treatment therapies

Market Segmentation Analysis

  • Disease Type: Growing need for effective treatments for alopecia universalis and alopecia totalis
  • End User: homecare treatments owing to their Convenience and cost-effectiveness

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Alopecia Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Alopecia Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Lilly's Olumiant (Baricitinib) Authorized in Canada for Severe Alopecia Areata Treatment

Health Canada has approved Eli Lilly and Company’s Olumiant (baricitinib) for the treatment of adults with severe alopecia areata, a condition characterized by significant hair loss. This authorization makes Olumiant the first JAK inhibitor approved in Canada specifically for this challenging condition. Clinical trials demonstrated that patients treated with Olumiant experienced notable hair regrowth compared to those who received a placebo.

HopeMed Advances Phase II Clinical Trials for Innovative Androgenetic Alopecia Treatment

HopeMed has progressed to phase II clinical trials with its promising treatment for androgenetic alopecia, commonly known as male or female pattern baldness. This treatment, utilizing the proprietary HMPL-3853 molecule, targets a unique pathway associated with hair loss, distinct from treatments currently available on the market. The decision to advance to phase II was supported by promising preliminary results from earlier phases, which indicated both efficacy and safety.

FDA Approves Pfizer's LITFULO (Ritlecitinib) for Severe Alopecia Treatment

The U.S. Food and Drug Administration (FDA) has officially approved Pfizer's LITFULO (ritlecitinib) for the treatment of adults and adolescents (12 years and older) suffering from severe alopecia areata. This marks a significant advancement in therapeutic options for individuals battling this challenging autoimmune disorder, which results in substantial hair loss. Clinical trials demonstrated that patients treated with LITFULO experienced notable hair regrowth compared to those who received a placebo.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Alopecia Treatment Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aclaris Therapeutics, Inc., AnaptysBio Inc., Apira Science, Inc., Apple Therapeutics Private Limited, Arcutis Biotherapeutics, Inc., Biocon Limited, Cipla, Inc., Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV, Follica, Inc., HCell Inc., iRestore Hair Growth System, KNOW Bio LLC, Merck & Co., Pfizer Inc., Regeneron Pharmaceuticals, Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Transitions Hair Pty Ltd., and Viviscal.

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Type

  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • Androgenetic Alopecia
  • Cicatricial Alopecia
  • Traction Alopecia

Route of Administration

  • Injectable
  • Oral
  • Topical

Gender

  • Female
  • Male
  • Treatment Option

Cosmetic Treatment

  • Hair Fiber Powders
  • Scalp Micropigmentation

Medical Treatment

  • Anthralin
  • Corticosteroid
  • JAK Inhibitors
  • Methotrexate
  • Topical Immunotherapy

Surgical Treatment

  • Follicular Unit Extraction
  • Hair Transplant Surgery
  • Scalp Reduction Treatment

End User

  • Dermatology Clinics
  • Homecare Setting

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
5.1.1.2. Growing awareness about hair loss and transplantation
5.1.1.3. Rise in income levels and increased healthcare spending
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies for alopecia treatments
5.1.3. Opportunities
5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
5.1.3.2. Rising investments and expansion of hair transplant clinics
5.1.4. Challenges
5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
5.2. Market Segmentation Analysis
5.2.1. Disease Type: Growing need for effective treatments for alopecia universalis and alopecia totalis
5.2.2. End User: homecare treatments owing to their Convenience and cost-effectiveness
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Alopecia Treatment Market, by Disease Type
6.1. Introduction
6.2. Alopecia Areata
6.3. Alopecia Totalis
6.4. Alopecia Universalis
6.5. Androgenetic Alopecia
6.6. Cicatricial Alopecia
6.7. Traction Alopecia
7. Alopecia Treatment Market, by Route of Administration
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical
8. Alopecia Treatment Market, by Gender
8.1. Introduction
8.2. Female
8.3. Male
9. Alopecia Treatment Market, by Treatment Option
9.1. Introduction
9.2. Cosmetic Treatment
9.3. Medical Treatment
9.4. Surgical Treatment
10. Alopecia Treatment Market, by End User
10.1. Introduction
10.2. Dermatology Clinics
10.3. Homecare Setting
11. Americas Alopecia Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Alopecia Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Alopecia Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Lilly's Olumiant (Baricitinib) Authorized in Canada for Severe Alopecia Areata Treatment
14.3.2. HopeMed Advances Phase II Clinical Trials for Innovative Androgenetic Alopecia Treatment
14.3.3. FDA Approves Pfizer's LITFULO (Ritlecitinib) for Severe Alopecia Treatment
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALOPECIA TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR FIBER POWDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR FIBER POWDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FOLLICULAR UNIT EXTRACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FOLLICULAR UNIT EXTRACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR TRANSPLANT SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR TRANSPLANT SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP REDUCTION TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP REDUCTION TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 125. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 126. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 127. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 130. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 131. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 132. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 133. CANADA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 134. CANADA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 135. CANADA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 136. CANADA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 137. CANADA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 138. CANADA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 139. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 140. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 141. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 142. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 143. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 144. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 145. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 146. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 147. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 148. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 149. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 150. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 151. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 152. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 153. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 154. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 155. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 156. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 157. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 158. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 163. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 164. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 165. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 166. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 167. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 168. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 169. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 170. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 171. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 172. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 173. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 174. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 176. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 180. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 182. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 184. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 186. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 188. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 190. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 192. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 193. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 194. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 195. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 196. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 197. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 198. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 199. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 200. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 201. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 202. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 203. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 204. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 205. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 206. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 207. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 208. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 209. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 210. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 211. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 212. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 213. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 214. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 215. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 216. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 217. CHINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 218. CHINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 219. CHINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 220. CHINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 221. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 222. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 223. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 226. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 227. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 228. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 229. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 230. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 231. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 232. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 233. INDIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 234. INDIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 235. INDIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 236. INDIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 237. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 238. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 239. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 240. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 241. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 242. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 243. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 244. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 245. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 246. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 247. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 248. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 249. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 250. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 251. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 252. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 253. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 254. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 255. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 256. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 257. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 258. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 259. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 260. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 261. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 262. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 263. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 264. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 265. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 266. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 267. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 268. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 269. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 270. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 271. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 272. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 273. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 274. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 275. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 276. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 277. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 278. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 279. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 280. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 281. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 282. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 283. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 284. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 285. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 286. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 287. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 288. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 289. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 290. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 291. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 292. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 293. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 294. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 295. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 296. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 297. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 298. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 299. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 300. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 301. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 302. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 303. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 304. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 305. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 306. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 307. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 308. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 309. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 310. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 311. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 312. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 313. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 314. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 315. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 316. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 317. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 318. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 319. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 320. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 321. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 322. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 323. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 324. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 325. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 326. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 327. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2023 (USD MILLION)
TABLE 328. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2024-2030 (USD MILLION)
TABLE 329. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2023 (USD MILLION)
TABLE 330. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2024-2030 (USD MILLION)
TABLE 331. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 332. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 333. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2023 (USD MILLION)
TABLE 334. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2024-2030 (USD MILLION)
TABLE 335. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 336. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 337. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
TABLE 338. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
TABLE 339. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 340. TAIWAN ALOPECIA TR

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • AnaptysBio Inc.
  • Apira Science, Inc.
  • Apple Therapeutics Private Limited
  • Arcutis Biotherapeutics, Inc.
  • Biocon Limited
  • Cipla, Inc.
  • Daiichi Sankyo Inc.
  • DR. KURT WOLFF GMBH & CO. KG
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • Fagron NV
  • Follica, Inc.
  • HCell Inc.
  • iRestore Hair Growth System
  • KNOW Bio LLC
  • Merck & Co.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • RepliCel Life Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Transitions Hair Pty Ltd.
  • Viviscal

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.81 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal

Related Topics

Related Reports

Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2024-2030 - Product Image

Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Alopecia Treatment Market Report by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Image

Alopecia Treatment Market Report by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Alopecia Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Alopecia Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Global Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), Treatment, Gender, Sales Channel, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), Treatment, Gender, Sales Channel, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030 - Product Image

Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Alopecia Drug Market

The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics. The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.